PDS Biotechnology Financials
| EU6 Stock | EUR 1.67 0.09 5.70% |
PDS |
Understanding current and past PDS Biotechnology Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of PDS Biotechnology's financial statements are interrelated, with each one affecting the others. For example, an increase in PDS Biotechnology's assets may result in an increase in income on the income statement.
PDS Biotechnology Stock Summary
PDS Biotechnology competes with TITANIUM TRANSPORTGROUP, Magic Software, Easy Software, Liberty Broadband, and CyberArk Software. PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey. PDS BIOTECHNOLOGY operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 15 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US70465T1079 |
| Business Address | 25B Vreeland Road, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.pdsbiotech.com |
| Phone | 800 208 3343 |
| Currency | EUR - Euro |
You should never invest in PDS Biotechnology without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of PDS Stock, because this is throwing your money away. Analyzing the key information contained in PDS Biotechnology's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
PDS Biotechnology Key Financial Ratios
There are many critical financial ratios that PDS Biotechnology's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that PDS Biotechnology Corp reports annually and quarterly.| Return On Equity | -0.49 | |||
| Return On Asset | -0.25 | |||
| Target Price | 19.71 | |||
| Number Of Employees | 22 | |||
| Beta | 1.91 |
PDS Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PDS Biotechnology's current stock value. Our valuation model uses many indicators to compare PDS Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PDS Biotechnology competition to find correlations between indicators driving PDS Biotechnology's intrinsic value. More Info.PDS Biotechnology Corp is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PDS Biotechnology's earnings, one of the primary drivers of an investment's value.PDS Biotechnology Corp Systematic Risk
PDS Biotechnology's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. PDS Biotechnology volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on PDS Biotechnology Corp correlated with the market. If Beta is less than 0 PDS Biotechnology generally moves in the opposite direction as compared to the market. If PDS Biotechnology Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one PDS Biotechnology Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of PDS Biotechnology is generally in the same direction as the market. If Beta > 1 PDS Biotechnology moves generally in the same direction as, but more than the movement of the benchmark.
PDS Biotechnology Thematic Clasifications
PDS Biotechnology Corp is part of Biotech investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services
This theme covers Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services. Get More Thematic Ideas
| Biotech | View |
PDS Biotechnology January 6, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of PDS Biotechnology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of PDS Biotechnology Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of PDS Biotechnology Corp based on widely used predictive technical indicators. In general, we focus on analyzing PDS Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build PDS Biotechnology's daily price indicators and compare them against related drivers.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 38.41 | |||
| Value At Risk | (8.81) | |||
| Potential Upside | 6.43 |
Complementary Tools for PDS Stock analysis
When running PDS Biotechnology's price analysis, check to measure PDS Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PDS Biotechnology is operating at the current time. Most of PDS Biotechnology's value examination focuses on studying past and present price action to predict the probability of PDS Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PDS Biotechnology's price. Additionally, you may evaluate how the addition of PDS Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |